Summary
Shown below is a summary of the data available. For each protein-protein complex, the number of mutations (#muts), the number of pairs of
kinetic rate constants (#kin), the number of entropies and enthalpies (#therm), and the relevant PDB structures of the complex (PDBs) are
shown.
Also shown is the proportion of mutations which are the interior (INT), surface (SUR) of the protein, when away from the binding interface,
as well as in the core (COR), support (SUP) and rim (RIM) of the binding site, as defined in
"A simple definition of structural regions in proteins and its use in analyzing interface evolution", ED Levy, J Mol Biol. 2010, 403(4):660-70).
The table also shows the number of mutations that are new additions to SKEMPI2 (new), the number of entries that have inequalities in either
the wild-type or mutant binding affinity (ineq) and the number of entries containing unfolded mutants or no detectable binding (n.b).
The final columns indicate the experimental methods employed: surface plasmon resonance (SPR), fluorescence (FL), spectroscopic inhibition assay
(IASP), other spectroscopic method (SP), radioactive ligand binding (RA), stopped flow fluorescence (SFFL), ELISA (ELISA), isothermal titration
calorimetry (ITC), kinetic exclusion assay (KinExA), radioligand inhibition assay (IARA), fluorescence inhibition assay (IAFL), Solid-phase
competitive-binding radioimmunoassay (CSPRIA), enzyme-linked functional assay (ELFA), biolayer interferometry (BI), or electrophoretic mobility
shift (EMSA), or other method (OTHER).
Protein 1 | Protein 2 | PDB | #muts | #kin | #therm | INT | SUR | COR | SUP | RIM | Ala | new | ineq | n.b | SPR | FL | ITC | IASP | RA | SFFL | SP | ELISA | IAFL | IARA | KinExA | BI | CSPRIA | ELFA | ESMA | OTHER |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turkey ovomucoid third domain | Streptomyces griseus proteinase B | 3SGB_E_I | 295 | 0 | 0 | 3.6 | 15.5 | 49.1 | 0.3 | 31.5 | 3.4 | 4 | 0 | 0 | 0 | 284 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2NU4_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2NU2_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2NU1_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2NU0_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1SGY_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1SGQ_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1SGP_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1SGN_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1SGE_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1SGD_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2SGQ_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1CT4_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1CT2_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1CT0_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1CSO_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2SGP_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 311 | 0 | 0 | 3.5 | 15.2 | 50.3 | 0.3 | 30.8 | 3.3 | 4 | 0 | 0 | 0 | 284 | 0 | 11 | 0 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Bovine alpha-chymotrypsin | Turkey ovomucoid third domain | 1CHO_EFG_I | 295 | 0 | 0 | 3.7 | 20.8 | 46.3 | 9.5 | 19.7 | 3.4 | 4 | 0 | 0 | 0 | 285 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Turkey ovomucoid third domain | Subtilisin Carlsberg | 1R0R_E_I | 284 | 0 | 0 | 3.1 | 17.4 | 43.7 | 9.6 | 26.3 | 3.7 | 4 | 0 | 0 | 0 | 279 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BLIP | TEM-1 beta-lactamase | 1JTG_A_B | 275 | 121 | 45 | 5.2 | 2.3 | 53.8 | 29.5 | 9.3 | 90.7 | 101 | 0 | 0 | 156 | 0 | 45 | 43 | 0 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
1S0W_A_C | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1XXM_A_C | 1 | 0 | 0 | 20 | 0 | 0 | 0 | 80 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 277 | 121 | 45 | 5.3 | 2.2 | 53.2 | 29.1 | 10.2 | 89.6 | 101 | 0 | 0 | 158 | 0 | 45 | 43 | 0 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | ||
Human leukocyte elastase | Turkey ovomucoid third domain | 1PPF_E_I | 259 | 0 | 0 | 3.3 | 19.7 | 42 | 0 | 35.1 | 3.9 | 4 | 0 | 0 | 0 | 258 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hGH binding protein | Human growth hormone | 1A22_A_B | 251 | 58 | 3 | 15.1 | 28.9 | 23.2 | 13.8 | 19 | 73.7 | 88 | 3 | 0 | 83 | 0 | 3 | 0 | 102 | 0 | 0 | 0 | 0 | 63 | 0 | 0 | 0 | 0 | 0 | 0 |
Urokinase plasminogen activator surface receptor | Urokinase-type plasminogen activator | 3BT1_A_U | 245 | 240 | 0 | 31.8 | 47.3 | 3.3 | 9.8 | 7.8 | 95.9 | 240 | 0 | 0 | 245 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HLA-A2 plus tax peptide | A6 TCR | 1AO7_ABC_DE | 212 | 97 | 1 | 4.4 | 2.4 | 51.9 | 13 | 28.3 | 46.9 | 212 | 2 | 10 | 211 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4FTV_ABC_DE | 18 | 6 | 0 | 9.1 | 0 | 45.5 | 6.1 | 39.4 | 57.6 | 18 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3D3V_ABC_DE | 9 | 0 | 0 | 0 | 0 | 66.7 | 0 | 33.3 | 83.3 | 9 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1QSF_ABC_DE | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1QRN_ABC_DE | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1QSE_ABC_DE | 1 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3QFJ_ABC_DE | 1 | 0 | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 243 | 104 | 2 | 4.6 | 2.1 | 52.3 | 11.9 | 29.1 | 48.5 | 243 | 2 | 12 | 241 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Integrin alpha-1 | AQC2 fab | 1MHP_HL_A | 118 | 2 | 0 | 12 | 24.7 | 19.9 | 24.1 | 19.3 | 3 | 118 | 2 | 24 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 93 | 0 | 0 | 23 | 0 | 0 | 0 | 0 | 0 |
2B2X_HL_A | 115 | 0 | 0 | 4.2 | 20.6 | 7.6 | 23.2 | 44.4 | 1 | 115 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92 | 0 | 0 | 23 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 233 | 2 | 0 | 6.1 | 21.6 | 10.6 | 23.4 | 38.4 | 1.4 | 233 | 2 | 48 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 185 | 0 | 0 | 46 | 0 | 0 | 0 | 0 | 0 | ||
Interferon alpha-2 | Interferon alpha/beta receptor 2 | 3S9D_A_B | 218 | 70 | 0 | 4.9 | 20.5 | 45.6 | 17.7 | 11.3 | 85.2 | 218 | 0 | 0 | 61 | 0 | 0 | 0 | 0 | 0 | 157 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3SE3_B_C | 2 | 2 | 0 | 0 | 0 | 100 | 0 | 0 | 50 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 220 | 72 | 0 | 4.8 | 20.1 | 46.7 | 17.3 | 11.1 | 84.4 | 220 | 0 | 0 | 61 | 0 | 0 | 0 | 0 | 0 | 159 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Prolactin | Prolactin receptor | 3MZG_A_B | 91 | 57 | 0 | 18 | 10 | 46 | 16 | 10 | 100 | 91 | 0 | 0 | 91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3NCB_A_B | 19 | 19 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 19 | 0 | 0 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3N0P_A_B | 10 | 10 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 10 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3N06_A_B | 10 | 10 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 10 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3NCC_A_B | 9 | 9 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 9 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 139 | 105 | 0 | 12.2 | 6.8 | 50 | 24.3 | 6.8 | 67.6 | 139 | 0 | 0 | 139 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Factor VIIa | Tissue factor | 1DAN_HL_UT | 130 | 74 | 0 | 18 | 29.2 | 26.1 | 6.8 | 19.9 | 91.9 | 0 | 0 | 0 | 74 | 0 | 0 | 0 | 0 | 0 | 0 | 31 | 0 | 0 | 0 | 0 | 0 | 25 | 0 | 0 |
HyHEL-10 | HEW Lysozyme | 3HFM_HL_Y | 122 | 45 | 12 | 0 | 0 | 79.7 | 15.5 | 4.7 | 48.6 | 12 | 1 | 10 | 0 | 0 | 12 | 62 | 0 | 0 | 48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
H-Ras1 | RalGDS-RBD | 1LFD_A_B | 118 | 25 | 55 | 6.7 | 24.2 | 30.3 | 3.6 | 35.2 | 58.8 | 93 | 1 | 0 | 0 | 0 | 56 | 0 | 0 | 25 | 0 | 0 | 37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Raf-RBD | H-Ras1 | 4G0N_A_B | 90 | 2 | 54 | 6.8 | 10.3 | 24.7 | 13 | 45.2 | 66.4 | 90 | 2 | 0 | 0 | 0 | 54 | 0 | 0 | 2 | 0 | 0 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3KUD_A_B | 18 | 0 | 0 | 15.4 | 19.2 | 38.5 | 0 | 26.9 | 32.7 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 108 | 2 | 54 | 9.1 | 12.6 | 28.3 | 9.6 | 40.4 | 57.6 | 108 | 2 | 0 | 0 | 0 | 54 | 0 | 0 | 2 | 0 | 0 | 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Barnase | Barstar | 1BRS_A_D | 94 | 68 | 31 | 1.4 | 5 | 58.3 | 21.6 | 13.7 | 71.2 | 0 | 0 | 0 | 4 | 0 | 31 | 0 | 0 | 50 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1B3S_A_D | 3 | 3 | 0 | 0 | 0 | 50 | 0 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1B2S_A_D | 3 | 3 | 0 | 0 | 0 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1B2U_A_D | 3 | 3 | 0 | 0 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1X1X_A_D | 1 | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1X1W_A_D | 1 | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 105 | 79 | 31 | 1.3 | 5.2 | 55.6 | 22.9 | 15 | 64.7 | 0 | 0 | 0 | 6 | 0 | 31 | 0 | 0 | 59 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
ACTR | CREB NCBD | 1KBH_A_B | 92 | 20 | 0 | 46.6 | 0 | 0 | 53.4 | 0 | 39.5 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IgG1-kappa D1.3 Fv | HEW Lysozyme | 1VFB_AB_C | 72 | 0 | 0 | 3.5 | 7 | 54.7 | 8.1 | 26.7 | 73.3 | 22 | 3 | 2 | 52 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1KIR_AB_C | 1 | 0 | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1KIP_AB_C | 1 | 0 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1KIQ_AB_C | 1 | 0 | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 75 | 0 | 3 | 3.4 | 6.7 | 55.1 | 9 | 25.8 | 70.8 | 22 | 3 | 2 | 52 | 20 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Interferon gamma receptor | mAbs A6 | 1JRH_LH_I | 74 | 15 | 0 | 9.1 | 25.3 | 35.4 | 13.1 | 17.2 | 47.5 | 0 | 0 | 0 | 55 | 0 | 0 | 0 | 0 | 0 | 0 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interferon alpha/beta receptor 1 | Interferon alpha-2 | 3SE3_B_A | 67 | 2 | 0 | 2.4 | 3.9 | 82.1 | 2.9 | 8.7 | 32.4 | 67 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CD4 | gp120 | 1GC1_G_C | 67 | 0 | 0 | 21.4 | 45.7 | 14.3 | 5.7 | 12.9 | 97.1 | 11 | 0 | 11 | 0 | 0 | 0 | 0 | 67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Human growth hormone | Prolactin receptor | 1BP3_A_B | 66 | 0 | 0 | 21.2 | 39.4 | 12.4 | 10.2 | 16.8 | 47.4 | 66 | 0 | 0 | 0 | 0 | 0 | 0 | 66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Colicin E9 immunity protein | Colicin E9 DNase | 1EMV_A_B | 59 | 51 | 0 | 13.9 | 48.3 | 17.8 | 8.3 | 11.7 | 32.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17 | 42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2GYK_A_B | 1 | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1FR2_A_B | 1 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2VLO_A_B | 1 | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2VLQ_A_B | 1 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2VLN_A_B | 1 | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2VLP_A_B | 1 | 1 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 65 | 57 | 0 | 14 | 46.8 | 18.3 | 9.7 | 11.3 | 31.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 | 44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
GM-CSF | GMR alpha | 4RS1_A_B | 64 | 0 | 0 | 21.1 | 4.4 | 35.6 | 14.4 | 24.4 | 65.6 | 64 | 4 | 18 | 0 | 0 | 0 | 0 | 33 | 0 | 0 | 0 | 0 | 31 | 0 | 0 | 0 | 0 | 0 | 0 |
Colicin E9 DNase | Colicin E2 immunity protein | 2WPT_A_B | 64 | 30 | 0 | 15.8 | 22.1 | 21.1 | 18.9 | 22.1 | 28.4 | 11 | 3 | 2 | 0 | 0 | 6 | 0 | 29 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GM-CSF | GMR alpha . cytokine receptor common subunit beta | 4NKQ_C_AB | 60 | 0 | 0 | 23.1 | 17.6 | 35.2 | 7.7 | 16.5 | 54.9 | 60 | 0 | 1 | 0 | 0 | 0 | 0 | 45 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 |
JM22 TCR | HLA-A2 plus flu peptide | 1OGA_ABC_DE | 58 | 38 | 10 | 13.8 | 5.2 | 48.3 | 12.1 | 20.7 | 70.7 | 44 | 8 | 0 | 48 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2VLR_ABC_DE | 2 | 1 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 60 | 39 | 11 | 13.3 | 5 | 46.7 | 15 | 20 | 68.3 | 45 | 8 | 0 | 49 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
HEW Lysozyme | HyHEL-63 fab | 1DQJ_AB_C | 39 | 0 | 0 | 0 | 0 | 69.2 | 26.9 | 3.8 | 100 | 0 | 0 | 0 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1XGT_AB_C | 4 | 0 | 4 | 0 | 0 | 0 | 100 | 0 | 25 | 4 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1XGR_AB_C | 4 | 0 | 4 | 0 | 0 | 0 | 100 | 0 | 25 | 4 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1XGQ_AB_C | 4 | 0 | 4 | 0 | 0 | 0 | 100 | 0 | 25 | 4 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1XGP_AB_C | 4 | 0 | 4 | 0 | 0 | 0 | 100 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1XGU_AB_C | 4 | 0 | 4 | 0 | 0 | 100 | 0 | 0 | 25 | 4 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 59 | 0 | 20 | 0 | 0 | 55.6 | 41.7 | 2.8 | 77.8 | 20 | 0 | 0 | 39 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
HLA-A2 plus MART-1 peptide | MEL5 TCR | 3HG1_ABC_DE | 53 | 0 | 0 | 21.6 | 10.8 | 33.3 | 19.8 | 14.4 | 13.5 | 53 | 0 | 45 | 53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AR2 mab | BoNT/A1 | 2NYY_DC_A | 32 | 0 | 0 | 22.2 | 2.8 | 30.6 | 5.6 | 38.9 | 52.8 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32 | 0 | 0 | 0 | 0 | 0 |
2NZ9_DC_A | 20 | 0 | 0 | 4.5 | 4.5 | 36.4 | 18.2 | 36.4 | 86.4 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 52 | 0 | 0 | 15.5 | 3.4 | 32.8 | 10.3 | 37.9 | 65.5 | 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 52 | 0 | 0 | 0 | 0 | 0 | ||
Axl | GAS6 | 2C5D_AB_CD | 20 | 5 | 0 | 22.7 | 13.6 | 36.4 | 0 | 27.3 | 22.7 | 20 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2C5D_A_C | 16 | 1 | 0 | 47.1 | 23.5 | 2.9 | 23.5 | 2.9 | 17.6 | 16 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | ||
4RA0_A_C | 15 | 1 | 0 | 21.1 | 42.1 | 0 | 36.8 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 51 | 7 | 0 | 29.3 | 25.9 | 14.7 | 19 | 11.2 | 13.8 | 51 | 1 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31 | 0 | 0 | 0 | 0 | 0 | ||
E6AP | UBCH7 | 1C4Z_ABC_D | 49 | 0 | 0 | 2 | 10 | 36 | 22 | 30 | 70 | 49 | 0 | 0 | 0 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BLIP | SHV-1 beta-lactamase | 2G2U_A_B | 47 | 0 | 0 | 9.1 | 0 | 70.1 | 15.6 | 5.2 | 58.4 | 11 | 0 | 0 | 0 | 0 | 0 | 47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3N4I_A_B | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2G2W_A_B | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 49 | 0 | 0 | 8.9 | 0 | 69.6 | 15.2 | 6.3 | 57 | 12 | 0 | 0 | 0 | 0 | 0 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
IgG1-kappa D1.3 Fv | E5.2 Fv | 1DVF_AB_CD | 47 | 0 | 0 | 0 | 0 | 55 | 18.3 | 26.7 | 98.3 | 1 | 0 | 1 | 47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
H3 tail | dHP1 Chromodomain | 1KNE_A_P | 46 | 0 | 0 | 0 | 2.5 | 0 | 0 | 97.5 | 2.5 | 46 | 0 | 0 | 0 | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Angiogenin | Ribonuclease inhibitor | 1A4Y_A_B | 46 | 46 | 0 | 3.1 | 4.7 | 57.8 | 25 | 9.4 | 84.4 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
VRC01 fab | gp120 | 3NGB_HL_G | 45 | 16 | 0 | 1.5 | 3.1 | 49.2 | 16.9 | 29.2 | 46.2 | 45 | 0 | 0 | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bovine alpha-chymotrypsin | BPTI | 1CBW_FGH_I | 45 | 15 | 13 | 11.1 | 4.4 | 62.2 | 8.9 | 13.3 | 64.4 | 13 | 0 | 0 | 0 | 0 | 13 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Antibody Jel42 | Histadine-containing protein HPr | 2JEL_LH_P | 44 | 0 | 0 | 11.4 | 38.6 | 22.7 | 6.8 | 20.5 | 13.6 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44 | 0 | 0 | 0 |
Fab-12 | VEGF | 1BJ1_HL_VW | 23 | 17 | 0 | 5.5 | 18.2 | 32.7 | 3.6 | 40 | 10.9 | 23 | 5 | 0 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1CZ8_HL_VW | 18 | 17 | 0 | 22.5 | 22.5 | 28.8 | 0 | 26.2 | 1.2 | 18 | 17 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 41 | 34 | 0 | 15.6 | 20.7 | 30.4 | 1.5 | 31.9 | 5.2 | 41 | 22 | 0 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Bovine trypsin | BPTI | 2FTL_E_I | 32 | 15 | 0 | 6.2 | 3.1 | 75 | 6.2 | 9.4 | 50 | 12 | 12 | 0 | 0 | 0 | 0 | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3BTT_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3BTW_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3BTQ_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3BTM_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3BTH_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3BTG_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3BTF_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3BTE_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3BTD_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 41 | 15 | 0 | 4.9 | 2.4 | 80.5 | 4.9 | 7.3 | 39 | 12 | 12 | 0 | 0 | 0 | 0 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Interleukin-4 | Interleukin-4 receptor | 1IAR_A_B | 40 | 36 | 0 | 2.5 | 20 | 47.5 | 20 | 10 | 45 | 4 | 0 | 4 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subtilisin BPN | Chymotrypsin inhibitor 2 | 1TM1_E_I | 26 | 10 | 0 | 13.3 | 0 | 70 | 13.3 | 3.3 | 60 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1TO1_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1TMG_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1TM7_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1TM3_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1TM5_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1TM4_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1Y3D_E_I | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1Y48_E_I | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1Y3C_E_I | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1Y4A_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1Y3B_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1Y34_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1Y33_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1Y1K_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 40 | 10 | 0 | 15.6 | 0 | 73.3 | 8.9 | 2.2 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 34 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
HLA-B8 plus EB peptide | LC13 TCR | 1MI5_ABC_DE | 39 | 17 | 0 | 17.9 | 15.4 | 33.3 | 15.4 | 17.9 | 94.9 | 39 | 14 | 0 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1G4 TCR | HLA-A2 plus NY-ESO peptide | 2BNR_ABC_DE | 26 | 26 | 0 | 26.9 | 3.8 | 30.8 | 11.5 | 26.9 | 84.6 | 26 | 0 | 0 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2PYE_ABC_DE | 5 | 4 | 0 | 0 | 0 | 37.8 | 8.1 | 54.1 | 5.4 | 5 | 1 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2P5E_ABC_DE | 5 | 4 | 0 | 9.3 | 0 | 58.1 | 9.3 | 23.3 | 7 | 5 | 1 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2BNQ_ABC_DE | 1 | 1 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 37 | 35 | 0 | 11.2 | 0.9 | 43.9 | 9.3 | 34.6 | 25.2 | 37 | 2 | 0 | 37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
BLIP-II | TEM-1 beta-lactamase | 1JTD_A_B | 36 | 36 | 0 | 0 | 0 | 50 | 30.6 | 19.4 | 100 | 36 | 0 | 0 | 0 | 0 | 0 | 25 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interleukin-13 | H2L6 fab | 3L5X_A_HL | 36 | 36 | 0 | 0 | 63.1 | 0 | 7.2 | 29.7 | 4.5 | 36 | 0 | 0 | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bone morphogenetic protein-2 | BMPR-IA receptor | 1REW_AB_C | 27 | 20 | 0 | 9.6 | 41.5 | 22.3 | 6.4 | 20.2 | 39.4 | 1 | 1 | 0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2QJB_AB_C | 3 | 3 | 0 | 22.2 | 22.2 | 7.4 | 22.2 | 25.9 | 22.2 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2QJA_AB_C | 3 | 3 | 0 | 21.1 | 21.1 | 21.1 | 15.8 | 21.1 | 15.8 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2QJ9_AB_C | 3 | 3 | 0 | 21.1 | 5.3 | 15.8 | 21.1 | 36.8 | 5.3 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 36 | 29 | 0 | 14.5 | 31.4 | 18.9 | 11.9 | 23.3 | 29.6 | 1 | 1 | 0 | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
H2-A plus 3K peptide | YAe62 TCR | 3C60_CD_AB | 35 | 0 | 0 | 11.4 | 34.3 | 17.1 | 11.4 | 25.7 | 100 | 35 | 0 | 0 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
J809.B5 TCR | H2-A plus 3K peptide | 4P23_CD_AB | 35 | 0 | 0 | 8.6 | 37.1 | 20 | 11.4 | 22.9 | 100 | 35 | 0 | 0 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
H2-A plus 3K peptide | 14.C6 TCR | 4P5T_CD_AB | 35 | 0 | 0 | 5.7 | 34.3 | 22.9 | 14.3 | 22.9 | 100 | 35 | 0 | 0 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Membrane-type serine protease 1 | E2 fab | 3BN9_B_CD | 35 | 0 | 0 | 5.7 | 22.9 | 34.3 | 2.9 | 34.3 | 77.1 | 10 | 2 | 0 | 0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HLA-B35 plus LPEP viral peptide | SB27 TCR | 2AK4_ABC_DE | 34 | 12 | 0 | 0 | 5.9 | 44.1 | 29.4 | 20.6 | 94.1 | 34 | 9 | 5 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Raf-RBD | Rap1a | 1C1Y_A_B | 18 | 0 | 0 | 0 | 14.3 | 23.8 | 4.8 | 57.1 | 52.4 | 18 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1GUA_A_B | 15 | 0 | 13 | 0 | 11.1 | 44.4 | 5.6 | 38.9 | 83.3 | 15 | 0 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 33 | 0 | 13 | 0 | 12.8 | 33.3 | 5.1 | 48.7 | 66.7 | 33 | 3 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
T. californica acetylcholinesterase | Fasciculin II | 1FSS_A_B | 33 | 23 | 0 | 0 | 0 | 65.1 | 0 | 34.9 | 0 | 33 | 3 | 0 | 0 | 0 | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HLA-A2 plus MART-1 peptide | DMF5 TCR | 3QDG_ABC_DE | 18 | 0 | 0 | 0 | 0 | 70 | 0 | 30 | 5 | 18 | 0 | 2 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4L3E_ABC_DE | 13 | 0 | 0 | 0 | 10.5 | 68.4 | 10.5 | 10.5 | 89.5 | 13 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 31 | 0 | 0 | 0 | 5.1 | 69.2 | 5.1 | 20.5 | 46.2 | 31 | 0 | 2 | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
erbB-2 | Affibody ZHER2:342 | 3MZW_A_B | 30 | 30 | 0 | 0 | 83.8 | 0 | 0 | 16.2 | 16.2 | 30 | 0 | 0 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
KRpep-2d | K-Ras | 5XCO_A_B | 29 | 2 | 0 | 0 | 42.6 | 44.7 | 0 | 12.8 | 57.4 | 29 | 10 | 0 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
D44.1 fab | HEW Lysozyme | 1MLC_AB_E | 29 | 1 | 0 | 3.2 | 16.8 | 46.3 | 12.6 | 21.1 | 22.1 | 29 | 3 | 0 | 0 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
VRC03 Fab | gp120 | 3SE8_HL_G | 28 | 0 | 0 | 0 | 3.6 | 42.9 | 21.4 | 32.1 | 100 | 28 | 0 | 0 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AML1 Runx1 Runt domain | Core-binding factor beta | 1E50_A_B | 22 | 0 | 0 | 4.3 | 8.7 | 56.5 | 13 | 17.4 | 95.7 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22 | 0 |
1H9D_A_B | 6 | 0 | 0 | 0 | 0 | 50 | 33.3 | 16.7 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | ||
Total: | 28 | 0 | 0 | 3.4 | 6.9 | 55.2 | 17.2 | 17.2 | 96.6 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22 | 6 | ||
2B4 TCR | I-Ek plus MCC peptide | 3QIB_ABP_CD | 27 | 24 | 0 | 0 | 10.3 | 58.6 | 0 | 31 | 55.2 | 27 | 3 | 0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Membrane-type serine protease 1 | S4 fab | 3NPS_A_BC | 27 | 0 | 0 | 11.1 | 40.7 | 22.2 | 0 | 25.9 | 100 | 0 | 0 | 0 | 0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Membrane-type serine protease 1 | BPTI | 1EAW_A_B | 27 | 0 | 0 | 0 | 48.1 | 7.4 | 14.8 | 29.6 | 100 | 0 | 0 | 0 | 0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TGF-beta type II receptor | Transforming growth factor beta 3 | 1KTZ_A_B | 27 | 2 | 0 | 22.2 | 3.7 | 29.6 | 11.1 | 33.3 | 77.8 | 0 | 0 | 0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BLIP-II | B. anthracis beta-lactamase | 3QHY_A_B | 25 | 25 | 0 | 0 | 0 | 32 | 44 | 24 | 100 | 25 | 0 | 0 | 0 | 0 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
gp120 | VRC-PG04 | 3SE9_HL_G | 25 | 0 | 0 | 0 | 4 | 40 | 20 | 36 | 100 | 25 | 0 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GET3 | GET4 | 4PWX_AB_CD | 25 | 0 | 0 | 0 | 16 | 32 | 12 | 40 | 76 | 25 | 7 | 0 | 0 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Human acetylcholinesterase | Fasciculin II | 1B41_A_B | 25 | 22 | 0 | 0 | 0 | 85.2 | 0 | 14.8 | 0 | 25 | 3 | 0 | 0 | 0 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R. flavefaciens Doc1a dockerin | R. flavefaciens ScaB cohesin 3 | 5M2O_A_B | 24 | 0 | 22 | 0 | 0 | 63.6 | 18.2 | 18.2 | 97 | 24 | 0 | 2 | 0 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HCMV glycoprotein B | 1G2 fab | 5C6T_HL_A | 24 | 20 | 0 | 6.5 | 0 | 41.9 | 22.6 | 29 | 96.8 | 24 | 0 | 4 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
C. cellulolyticum cipC cohesin | C. cellulolyticum celCCA dockerin | 2VN5_A_B | 24 | 0 | 24 | 0 | 54.8 | 34.5 | 7.1 | 3.6 | 60.7 | 24 | 0 | 0 | 0 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interleukin-13 | Lebrikizumab fab | 4I77_HL_Z | 24 | 0 | 0 | 0 | 0 | 33.3 | 25 | 41.7 | 58.3 | 24 | 24 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
B7 TCR | HLA-A2 plus tax peptide | 1BD2_ABC_DE | 24 | 4 | 0 | 0 | 0 | 83.9 | 16.1 | 0 | 64.5 | 24 | 0 | 2 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FcRn | Human Serum Albumin | 4K71_A_BC | 23 | 7 | 0 | 23.1 | 0 | 23.1 | 50 | 3.8 | 3.8 | 23 | 0 | 1 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Protein A/Z | IgG1 Fc | 1FC2_C_D | 23 | 14 | 0 | 17.4 | 8.7 | 17.4 | 8.7 | 47.8 | 34.8 | 9 | 0 | 0 | 14 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Metalloproteinase inhibitor 1 | MMP1 Interstitial collagenase | 2J0T_A_D | 23 | 0 | 0 | 6.2 | 0 | 59.4 | 3.1 | 31.2 | 25 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Iron-regulated surface determinant protein H | Human metHaemoglobin | 3SZK_AB_C | 21 | 0 | 0 | 19 | 42.9 | 14.3 | 4.8 | 19 | 100 | 21 | 0 | 0 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HLA-A2 plus MART-1 peptide | a24b17 TCR | 4JFE_ABC_DE | 7 | 0 | 0 | 0 | 0 | 84.6 | 15.4 | 0 | 46.2 | 7 | 0 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4JFD_ABC_DE | 7 | 0 | 0 | 0 | 0 | 76.9 | 23.1 | 0 | 46.2 | 7 | 0 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
4JFF_ABC_DE | 7 | 0 | 0 | 0 | 0 | 42.9 | 57.1 | 0 | 100 | 7 | 0 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 21 | 0 | 0 | 0 | 0 | 72.7 | 27.3 | 0 | 57.6 | 21 | 0 | 3 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
RNase A | Ribonuclease inhibitor | 1Z7X_W_X | 21 | 17 | 0 | 0 | 0 | 50 | 34.6 | 15.4 | 92.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
Protein kinase byr2 | H-Ras1 | 1K8R_A_B | 20 | 0 | 0 | 4.8 | 33.3 | 42.9 | 9.5 | 9.5 | 66.7 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interferon alpha/beta receptor 2 | Interferon omega-1 | 3SE4_B_C | 20 | 0 | 0 | 0 | 0 | 90.9 | 4.5 | 4.5 | 77.3 | 20 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ubiquitin conjugation factor E4 | Rad23 | 3M62_A_B | 20 | 0 | 18 | 0 | 5 | 40 | 15 | 40 | 100 | 20 | 0 | 2 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Epidermal growth factor receptor | Cetuximab fab | 1YY9_CD_A | 19 | 11 | 0 | 11.5 | 42.3 | 15.4 | 26.9 | 3.8 | 23.1 | 19 | 0 | 0 | 11 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DMF5 TCR | HLA-A2 plus MART-1 derived peptide | 3QDJ_ABC_DE | 19 | 0 | 0 | 0 | 0 | 61.9 | 9.5 | 28.6 | 4.8 | 19 | 1 | 2 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Chemotaxis protein CheY | Chemotaxis protein CheA | 1FFW_A_B | 19 | 0 | 2 | 15.8 | 26.3 | 15.8 | 15.8 | 26.3 | 42.1 | 2 | 0 | 0 | 0 | 8 | 2 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Beta-chain of 14.3.d | Staphylococcal enterotoxin C3 | 1JCK_A_B | 19 | 0 | 0 | 15.8 | 0 | 52.6 | 10.5 | 21.1 | 100 | 12 | 3 | 2 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
E. hirae V1-ATPase A3B3 complex | E. hirae V1-ATPase DF complex | 3VR6_ABCDEF_GH | 18 | 0 | 0 | 3.2 | 9.5 | 60.3 | 4.8 | 22.2 | 82.5 | 18 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interferon alpha/beta receptor 1 | Interferon omega-1 | 3SE4_B_A | 18 | 0 | 0 | 5.6 | 11.1 | 72.2 | 5.6 | 5.6 | 83.3 | 18 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A. cellulolyticus scaB dockerin | A. cellulolyticus scaC cohesin | 4UYQ_A_B | 9 | 8 | 0 | 3.6 | 53.6 | 25 | 17.9 | 0 | 0 | 9 | 0 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4UYP_A_D | 9 | 8 | 0 | 3.6 | 53.6 | 25 | 17.9 | 0 | 0 | 9 | 0 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 18 | 16 | 0 | 3.6 | 53.6 | 25 | 17.9 | 0 | 0 | 18 | 0 | 2 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
UCH-L3 | Ubiquitin | 1XD3_A_B | 18 | 0 | 0 | 0 | 33.3 | 22.2 | 22.2 | 22.2 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 |
HIV-1 capsid protein | Cyclophilin A | 1AK4_A_D | 17 | 0 | 0 | 4.3 | 4.3 | 39.1 | 0 | 52.2 | 34.8 | 2 | 1 | 0 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1M9E_A_D | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 18 | 0 | 0 | 4.2 | 4.2 | 37.5 | 0 | 54.2 | 33.3 | 2 | 1 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
ILA1 TCR | HLA-A2 plus telomerase peptide | 4MNQ_ABC_DE | 17 | 14 | 0 | 20.6 | 11.8 | 41.2 | 8.8 | 17.6 | 17.6 | 17 | 0 | 3 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R11.1.6 | K-Ras | 5UFE_A_B | 9 | 0 | 0 | 0 | 73.3 | 0 | 0 | 26.7 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
5UFQ_A_C | 7 | 0 | 0 | 0 | 60 | 0 | 0 | 40 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | ||
Total: | 16 | 0 | 0 | 0 | 68 | 0 | 0 | 32 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | ||
HLA-A2 plus MART-1 peptide | RD1-MART1 TCR | 5E9D_AB_CDE | 16 | 0 | 0 | 22.6 | 48.4 | 6.5 | 0 | 22.6 | 0 | 16 | 0 | 0 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cytochrome C peroxidase | Cytochrome C | 2PCC_A_B | 12 | 0 | 12 | 0 | 0 | 38.9 | 0 | 61.1 | 83.3 | 0 | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2B12_A_B | 1 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2B11_A_B | 1 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2B10_A_B | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2B0Z_A_B | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 16 | 0 | 12 | 0 | 0 | 31.8 | 9.1 | 59.1 | 68.2 | 0 | 0 | 0 | 0 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Immunoglobulin fab 5G9 | Tissue factor | 1AHW_AB_C | 16 | 0 | 0 | 4 | 8 | 32 | 24 | 32 | 88 | 5 | 5 | 0 | 0 | 0 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ephrin type-A receptor 2 SAM | SHIP2 SAM | 2KSO_A_B | 15 | 0 | 10 | 0 | 3.8 | 23.1 | 0 | 73.1 | 15.4 | 15 | 2 | 5 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Actin capping protein | Myotropin | 3AAA_AB_C | 15 | 0 | 0 | 0 | 0 | 36.8 | 21.1 | 42.1 | 52.6 | 15 | 0 | 4 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
erbB-2 | Herceptin | 1N8Z_AB_C | 15 | 14 | 0 | 8.3 | 16.7 | 45.8 | 20.8 | 8.3 | 33.3 | 15 | 0 | 1 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Phosphatidylinositol 3-kinase | H-Ras1 | 1HE8_A_B | 15 | 0 | 0 | 3.4 | 13.8 | 6.9 | 51.7 | 24.1 | 31 | 2 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sperm-egg fusion protein Juno | Sperm-egg fusion protein Izumo | 5F4E_A_B | 14 | 14 | 0 | 7.1 | 7.1 | 57.1 | 0 | 28.6 | 71.4 | 14 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 0 | 0 | 0 | 0 |
SYG-1 D1-D2 | SYG-2 D1-D4 | 4OFY_A_D | 13 | 0 | 0 | 0 | 0 | 23.5 | 58.8 | 17.6 | 100 | 13 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Caf1An | Caf1M:Caf1 | 4B0M_A_BM | 13 | 0 | 0 | 12.5 | 0 | 50 | 31.2 | 6.2 | 56.2 | 13 | 2 | 1 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Killer cell immunoglobulin-like receptor 2DS2 | HLA-A-11 plus A14 peptide | 4N8V_G_ABC | 13 | 0 | 0 | 7.1 | 0 | 57.1 | 21.4 | 14.3 | 71.4 | 13 | 0 | 9 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bone morphogenetic protein-2 | Crossveinless 2 | 3BK3_A_C | 13 | 6 | 0 | 0 | 0 | 53.8 | 0 | 46.2 | 38.5 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fasciculin | Mouse acetylcholinesterase | 1MAH_A_F | 13 | 6 | 0 | 11.1 | 0 | 44.4 | 44.4 | 0 | 5.6 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HLA-DQ plus gliadin-alpha2 peptide | D2 TCR | 4OZG_ABJ_GH | 12 | 0 | 0 | 0 | 0 | 58.3 | 25 | 16.7 | 75 | 12 | 3 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CD200 | CD200R | 4BFI_A_B | 12 | 0 | 0 | 0 | 25 | 66.7 | 8.3 | 0 | 25 | 12 | 0 | 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
11K2 scFv | MCP-1 | 2BDN_HL_A | 12 | 0 | 5 | 16.7 | 0 | 0 | 0 | 83.3 | 0 | 12 | 0 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DSK2 | Ubiquitin conjugation factor E4 | 3M63_A_B | 12 | 0 | 12 | 0 | 12.5 | 37.5 | 25 | 25 | 68.8 | 12 | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Plasma retinol-binding protein | Transthyretin | 1QAB_ABCD_E | 12 | 0 | 0 | 41.7 | 33.3 | 8.3 | 12.5 | 4.2 | 33.3 | 12 | 0 | 3 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ZipA | FtsZ fragment | 1F47_A_B | 12 | 0 | 0 | 0 | 0 | 33.3 | 0 | 66.7 | 83.3 | 0 | 0 | 0 | 10 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
p53 core domain | 53BP2 | 1YCS_A_B | 11 | 0 | 0 | 69.8 | 0 | 20.9 | 7 | 2.3 | 20.9 | 11 | 0 | 5 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MDMX | PMI peptide | 3EQY_A_C | 11 | 0 | 0 | 0 | 18.2 | 36.4 | 0 | 45.5 | 100 | 11 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MDM2 | PMI peptide | 3EQS_A_B | 10 | 0 | 0 | 0 | 10 | 40 | 0 | 50 | 100 | 10 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3LNZ_A_B | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 11 | 0 | 0 | 0 | 18.2 | 36.4 | 0 | 45.5 | 90.9 | 11 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Gankyrin | S6 ATPase | 2DVW_A_B | 11 | 0 | 10 | 0 | 0 | 72.2 | 11.1 | 16.7 | 94.4 | 11 | 0 | 1 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
gp120 | b13 fab | 3IDX_HL_G | 11 | 11 | 0 | 26.7 | 71.7 | 0 | 1.7 | 0 | 15 | 11 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
b12 fab | gp120 | 2NY7_HL_G | 11 | 11 | 0 | 27.6 | 65.5 | 0 | 3.4 | 3.4 | 15.5 | 11 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DNA repair protein recO | Single-stranded DNA-binding protein | 3Q8D_A_E | 11 | 0 | 0 | 0 | 54.5 | 18.2 | 9.1 | 18.2 | 63.6 | 11 | 3 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
C. thermophilum ERB1 | C. thermophilum YTM1 | 5CYK_A_B | 5 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 12.5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 |
5CXB_A_B | 5 | 0 | 0 | 0 | 0 | 80 | 0 | 20 | 20 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | ||
Total: | 10 | 0 | 0 | 0 | 0 | 92.3 | 0 | 7.7 | 15.4 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | ||
IL-1RAcP | PTP delta | 4YFD_A_B | 10 | 0 | 0 | 5.6 | 27.8 | 50 | 5.6 | 11.1 | 61.1 | 10 | 0 | 2 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Protein A/Z | Z-dependent protease inhibitor | 3F1S_A_B | 10 | 0 | 0 | 0 | 0 | 90 | 0 | 10 | 80 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
eOD-GT6 | VRC01 fab | 4JPK_HL_A | 10 | 9 | 0 | 9.1 | 27.3 | 9.1 | 27.3 | 27.3 | 9.1 | 10 | 0 | 1 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HER2 | Fab37 | 3N85_A_LH | 10 | 10 | 0 | 10 | 0 | 30 | 40 | 20 | 10 | 10 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Survivin | T3 phosphorylated H3(1-15) peptide | 3UIG_A_P | 10 | 0 | 5 | 0 | 0 | 63.6 | 27.3 | 9.1 | 81.8 | 10 | 0 | 5 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CNTO607 fab | Interleukin-13 | 3G6D_LH_A | 10 | 0 | 0 | 15 | 52.5 | 22.5 | 0 | 10 | 22.5 | 10 | 1 | 2 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subtilisin BPN | Streptomyces subtilisin inhibitor | 2SIC_E_I | 10 | 8 | 0 | 0 | 0 | 100 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HEW Lysozyme | HyHEL-5 fab | 1YQV_HL_Y | 9 | 0 | 9 | 60 | 10 | 30 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PDE delta | K-Ras | 5TAR_A_B | 9 | 0 | 0 | 50 | 0 | 30 | 0 | 20 | 90 | 9 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IL1RAPL1 | PTP delta | 4YH7_A_B | 9 | 0 | 0 | 0 | 41.2 | 29.4 | 17.6 | 11.8 | 58.8 | 9 | 0 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1968 Hemagglutinin | CR8043 fab | 4NM8_ABCDEF_HL | 9 | 0 | 0 | 0 | 0 | 55.6 | 0 | 44.4 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 |
Ataxin-1 | Capicua peptide | 4J2L_A_CD | 9 | 0 | 0 | 0 | 0 | 42.9 | 57.1 | 0 | 35.7 | 9 | 0 | 1 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MST4 | MO25 | 4FZA_A_B | 9 | 0 | 0 | 9.1 | 0 | 54.5 | 27.3 | 9.1 | 45.5 | 9 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 |
Limit dextrinase inhibitor | Limit dextrinase | 4CVW_A_C | 9 | 7 | 0 | 0 | 0 | 80 | 20 | 0 | 20 | 9 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
B domain of Protein G | IgG1 Fc | 1FCC_A_C | 9 | 0 | 0 | 0 | 0 | 70 | 0 | 30 | 100 | 1 | 1 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Carboxypeptidase A | Potato carboxypeptidase inhibitor | 4CPA_A_I | 9 | 0 | 0 | 10 | 0 | 70 | 20 | 0 | 10 | 1 | 1 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Syntaxin-1A | Munc18a | 4JEU_A_B | 8 | 0 | 8 | 20 | 10 | 70 | 0 | 0 | 90 | 8 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tai4 | Tae4 | 4HFK_A_BD | 8 | 8 | 0 | 0 | 0 | 50 | 25 | 25 | 100 | 8 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AHIII TCR | HLA-A2 plus P1049 peptide | 1LP9_ABC_EF | 4 | 3 | 1 | 0 | 0 | 50 | 50 | 0 | 100 | 4 | 0 | 0 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2J8U_ABC_EF | 2 | 1 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2JCC_ABC_EF | 1 | 1 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
2UWE_ABC_EF | 1 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 8 | 6 | 2 | 12.5 | 0 | 37.5 | 50 | 0 | 50 | 8 | 0 | 0 | 6 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Subtype N9 neuraminidase | Antibody NC10 | 1NMB_N_LH | 8 | 7 | 0 | 0 | 0 | 87.5 | 0 | 12.5 | 12.5 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NucA nuclease | NuiA nuclease inhibitor | 2O3B_A_B | 8 | 0 | 0 | 0 | 0 | 55.6 | 0 | 44.4 | 55.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
Arc1p | GluRS | 2HRK_A_B | 8 | 0 | 0 | 0 | 0 | 87.5 | 0 | 12.5 | 50 | 5 | 0 | 5 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fibrinogen-binding protein Efb-C | Complement C3d | 2GOX_A_B | 4 | 2 | 2 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3D5R_A_C | 2 | 1 | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3D5S_A_C | 2 | 1 | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 8 | 4 | 4 | 0 | 0 | 100 | 0 | 0 | 50 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Staphylococcal enterotoxin B | Beta-chain of 14.3.d | 1SBB_A_B | 8 | 0 | 0 | 0 | 0 | 33.3 | 0 | 66.7 | 0 | 5 | 1 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
C. thermocellum CipB dockerin | C. thermocellum ScaC2 cohesin 2 | 5K39_A_B | 7 | 0 | 5 | 0 | 0 | 71.4 | 0 | 28.6 | 100 | 7 | 0 | 2 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PlexinB2 | PDZ-RhoGEF | 5E6P_A_B | 7 | 0 | 0 | 0 | 0 | 85.7 | 14.3 | 0 | 57.1 | 7 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Slitrk2 LRR1 | PTP delta | 4Y61_A_B | 7 | 0 | 0 | 0 | 0 | 62.5 | 12.5 | 25 | 87.5 | 7 | 0 | 4 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fc gamma receptor 1 | IgG1 Fc | 4X4M_AB_E | 7 | 0 | 0 | 0 | 66.7 | 33.3 | 0 | 0 | 66.7 | 7 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MST3 | MO25 | 4O27_A_B | 7 | 0 | 0 | 14.3 | 0 | 57.1 | 14.3 | 14.3 | 57.1 | 7 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 |
Bacterioferritin-associated ferredoxin | Bacterioferritin | 4E6K_AB_G | 7 | 0 | 0 | 0 | 38.5 | 30.8 | 0 | 30.8 | 92.3 | 7 | 0 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
erbB-2 | bH1 Fab | 3BE1_HL_A | 7 | 4 | 0 | 7.6 | 43 | 11.4 | 1.3 | 36.7 | 15.2 | 7 | 0 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hACE3 | SARS-CoV RBD | 2AJF_A_E | 7 | 0 | 0 | 0 | 0 | 71.4 | 28.6 | 0 | 71.4 | 7 | 0 | 4 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NL63-CoV RBD | hACE3 | 3KBH_A_E | 7 | 0 | 0 | 0 | 0 | 57.1 | 28.6 | 14.3 | 71.4 | 7 | 0 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Activin A | Follistatin | 2B0U_AB_C | 7 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 42.9 | 7 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Activin A | Follistatin-like 3 | 3B4V_AB_C | 7 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 42.9 | 7 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Myostatin | Follistatin | 3HH2_AB_C | 7 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 42.9 | 7 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Myostatin | Follistatin-like 3 | 3SEK_AB_C | 7 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 42.9 | 7 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subtilisin Savinase | Alpha-amylase/subtilisin inhibitor | 3BX1_A_C | 7 | 0 | 0 | 0 | 0 | 57.1 | 42.9 | 0 | 28.6 | 7 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Protein inscuteable homolog (INSC) | G-protein-signaling modulator 2 (LGN) | 3SF4_A_D | 7 | 0 | 0 | 0 | 0 | 77.8 | 22.2 | 0 | 22.2 | 7 | 0 | 2 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Integrin alpha-L | Intercellular adhesion molecule I | 1MQ8_A_B | 7 | 7 | 0 | 54.5 | 45.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cbl-b UBA | Ubiquitin | 2OOB_A_B | 7 | 0 | 0 | 30.8 | 7.7 | 38.5 | 0 | 23.1 | 0 | 3 | 3 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
VavS | Growth factor receptor-bound protein 2 | 1GCQ_AB_C | 7 | 0 | 0 | 0 | 0 | 71.4 | 28.6 | 0 | 57.1 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ephrin type-A receptor 3 | Ephrin-A5 | 4L0P_A_B | 6 | 0 | 0 | 16.7 | 50 | 16.7 | 16.7 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
C. thermocellum XylY dockerin | C. thermocellum CipA cohesin 2 | 1OHZ_A_B | 5 | 0 | 0 | 0 | 53.8 | 46.2 | 0 | 0 | 61.5 | 5 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2CCL_A_B | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 6 | 0 | 0 | 0 | 60 | 40 | 0 | 0 | 53.3 | 6 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Latrophilin-3 OLF domain | FLRT3 LRR domain | 4YEB_A_B | 6 | 0 | 0 | 33.3 | 33.3 | 0 | 33.3 | 0 | 50 | 6 | 0 | 2 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STK25 | MO25 | 4NZW_A_B | 6 | 0 | 0 | 0 | 0 | 50 | 16.7 | 33.3 | 83.3 | 6 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 |
G(q) alpha | PLC beta 3 | 4GNK_A_B | 6 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 70 | 6 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Staphylococcal enterotoxin B | 3E2 fab | 3W2D_A_HL | 6 | 4 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 6 | 0 | 2 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
VEGF | bH1 Fab | 3BDY_HL_V | 6 | 3 | 0 | 0 | 43.9 | 19.7 | 3 | 33.3 | 15.2 | 6 | 0 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ubiquitin | Tumor susceptibility gene 101 protein | 1S1Q_A_B | 6 | 0 | 0 | 0 | 0 | 16.7 | 33.3 | 50 | 100 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cytochrome C peroxidase | Non-cognate Cytochrome C | 2PCB_A_B | 6 | 0 | 6 | 0 | 16.7 | 16.7 | 0 | 66.7 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Rac-1 | p67phox | 1E96_A_B | 6 | 0 | 0 | 0 | 66.7 | 16.7 | 0 | 16.7 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bovine alpha-chymotrypsin | Eglin c | 1ACB_E_I | 6 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Eglin c | Subtilisin Carlsberg | 1CSE_E_I | 6 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IGF-1R | IGF-I | 1WQJ_I_B | 5 | 5 | 0 | 33.3 | 50 | 0 | 0 | 16.7 | 100 | 5 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Alanine-glyoxylate aminotransferase | PEX5P | 3R9A_AC_B | 5 | 0 | 5 | 40 | 0 | 0 | 40 | 20 | 20 | 5 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bovine trypsin | Mung bean inhibitor peptide | 1SMF_E_I | 5 | 0 | 0 | 0 | 0 | 80 | 0 | 20 | 100 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inhibitor of vertebrate lysozyme | HEW Lysozyme | 1UUZ_A_D | 5 | 0 | 0 | 0 | 0 | 20 | 0 | 80 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Plexin-C1 | A39R | 3NVN_B_A | 4 | 0 | 1 | 0 | 0 | 25 | 75 | 0 | 0 | 4 | 0 | 2 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Plexin-C1 | Semaphorin-7A | 3NVQ_B_A | 4 | 0 | 0 | 0 | 0 | 25 | 75 | 0 | 0 | 4 | 0 | 2 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CSL311 fab | Cytokine receptor common subunit beta | 5DWU_HL_AB | 4 | 0 | 0 | 75 | 0 | 0 | 25 | 0 | 100 | 4 | 0 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MERS-CoV envolope protein S | MERS-27 fab | 4ZS6_HL_A | 4 | 0 | 0 | 0 | 0 | 75 | 0 | 25 | 100 | 4 | 0 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interleukin-17 receptor A | Interleukin-17a | 4HSA_AB_C | 4 | 4 | 0 | 0 | 50 | 25 | 0 | 25 | 0 | 4 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IGFBP1 | IGF-I | 2DSQ_I_G | 4 | 4 | 0 | 25 | 75 | 0 | 0 | 0 | 100 | 4 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interleukin-13 | Interleukin-13 receptor subunit alpha-2 | 3LB6_A_C | 4 | 4 | 0 | 0 | 0 | 50 | 25 | 25 | 100 | 4 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Designed Ankyrin Repeat Protein H10-2-G | erbB-2 | 4HRN_A_D | 4 | 4 | 0 | 0 | 0 | 75 | 0 | 25 | 100 | 4 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CAR D1 domain | AD12 knob protein | 1KAC_A_B | 2 | 0 | 0 | 0 | 0 | 50 | 0 | 50 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1P6A_A_B | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
1P69_A_B | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 4 | 0 | 0 | 0 | 0 | 75 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Mutant trypsinogen | BPTI | 1FY8_E_I | 2 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1F5R_A_I | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
3TGK_E_I | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 4 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Subtype N9 neuraminidase | Antibody NC41 scFv | 1NCA_N_LH | 4 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Human Angiotensin-converting enzyme 2 | SARS spike protein receptor binding domain | 2AJF_A_E | 4 | 4 | 0 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bovine beta-actin | Bovine profilin | 2BTF_A_P | 4 | 0 | 0 | 0 | 0 | 50 | 25 | 25 | 50 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TRP region of PEX5 | Sterol carrier protein 2 | 2C0L_A_B | 4 | 0 | 3 | 100 | 0 | 0 | 0 | 0 | 25 | 1 | 0 | 1 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MdiaN-TSH | M. musculus Cdc42 | 3EG5_A_B | 3 | 0 | 3 | 0 | 0 | 75 | 25 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Plexin-B1 | Rnd-1 | 2REX_A_B | 3 | 0 | 2 | 0 | 0 | 66.7 | 0 | 33.3 | 0 | 3 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Vaccinia L1 | M12B9 fab | 4U6H_AB_E | 3 | 2 | 0 | 0 | 0 | 66.7 | 0 | 33.3 | 100 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
Epidermal growth factor receptor | Nanobody EgA1 | 4KRO_A_B | 3 | 0 | 0 | 0 | 50 | 50 | 0 | 0 | 75 | 3 | 2 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Epidermal growth factor receptor | Nanobody 7D12 | 4KRL_A_B | 3 | 0 | 0 | 0 | 0 | 75 | 0 | 25 | 75 | 3 | 2 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LysZ | LysW | 3WWN_A_B | 3 | 0 | 3 | 0 | 0 | 33.3 | 0 | 66.7 | 0 | 3 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BTLA | HVEM | 2AW2_A_B | 3 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 100 | 3 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hemagglutinin HA2 | Antibody 2D1 | 3LZF_AB_HL | 3 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hemagglutinin HA2 | Antibody 1F1 | 4GXU_ABCDEF_MN | 3 | 0 | 0 | 0 | 0 | 50 | 0 | 50 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FERM and PDZ domain-containing protein 4 (FRMPD4) | G-protein-signaling modulator 2 (LGN) | 4WND_A_B | 3 | 0 | 0 | 0 | 0 | 50 | 50 | 0 | 0 | 3 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FERM and PDZ domain-containing protein 1 (FRMPD1) peptide | G-protein-signaling modulator 2 (LGN) | 4G2V_A_B | 3 | 0 | 0 | 0 | 50 | 0 | 50 | 0 | 0 | 3 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CAR D1 domain | CAV-2 | 2J1K_C_T | 3 | 0 | 0 | 0 | 33.3 | 33.3 | 0 | 33.3 | 66.7 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bovine alpha-chymotrypsin | Ecotin | 1N8O_ABC_E | 3 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IgG1 lambda fab | Flu virus hemagglutinin | 2VIR_AB_C | 2 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2VIS_AB_C | 1 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 3 | 2 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Mlc transcription regulator | PTS glucose-specific enzyme EIICB | 3BP8_A_C | 3 | 3 | 0 | 0 | 0 | 50 | 50 | 0 | 50 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HIV-1 Nef | Fyn SH3 domain R96I mutant | 1EFN_A_B | 3 | 0 | 0 | 0 | 25 | 75 | 0 | 0 | 25 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
B. subtilis endoxylanase | TAXI-I | 2B42_A_B | 3 | 3 | 0 | 0 | 0 | 100 | 0 | 0 | 33.3 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Smad4 | Smad3 | 1U7F_B_AC | 2 | 0 | 2 | 0 | 0 | 50 | 0 | 50 | 100 | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Nectin-1 | HSV-1 gD | 3U82_A_B | 2 | 1 | 0 | 0 | 0 | 60 | 20 | 20 | 100 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Nectin-1 | HSV-2 gD | 4MYW_A_B | 2 | 1 | 0 | 0 | 0 | 40 | 40 | 20 | 100 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Epidermal growth factor receptor | Nanobody 9G8 | 4KRP_A_B | 2 | 0 | 0 | 0 | 66.7 | 0 | 0 | 33.3 | 66.7 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Survivin | Histone H3(1-10) peptide | 3UII_A_P | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 100 | 33.3 | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A6 TCR | HLA-A2 plus HuD peptide | 3PWP_ABC_DE | 2 | 0 | 0 | 33.3 | 0 | 0 | 66.7 | 0 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bovine alpha-chymotrypsin | PMP-D2v insect inhibitor | 1GL0_E_I | 2 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bovine alpha-chymotrypsin | PMP-C insect inhibitor | 1GL1_A_I | 2 | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cdc42-GAP | Cdc42 | 1GRN_A_B | 2 | 0 | 0 | 0 | 50 | 0 | 0 | 50 | 0 | 1 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Mono-ADP-ribosyltransferase C3 | Ras-related protein Ral-A | 2A9K_A_B | 2 | 0 | 1 | 0 | 0 | 50 | 0 | 50 | 50 | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ephrin-B2 | Ephrin type-B receptor 4 | 2HLE_A_B | 2 | 0 | 2 | 0 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Type II IgNAR | HEW Lysozyme | 2I26_N_L | 2 | 2 | 0 | 0 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subtilisin BPN | Eglin c | 1SIB_E_I | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1SBN_E_I | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total: | 2 | 0 | 0 | 50 | 0 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Rnd-1 | Plexin-A2 | 3Q3J_A_B | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DhaK | DhaR(N) | 4LRX_AB_CD | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SOCS2-Elongin BC complex | N-terminal fragment of Cullin5 | 4JGH_ABC_D | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 100 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LSD2 | Histone H3.3 peptide | 4GU0_A_E | 1 | 0 | 0 | 0 | 0 | 33.3 | 0 | 66.7 | 100 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
G(q) alpha | RGS2 | 4EKD_A_B | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Survivin | SmacN | 3UIH_A_P | 1 | 0 | 1 | 0 | 0 | 50 | 0 | 50 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Neuroligin-1 | Neurexin-1-beta | 3BIW_A_E | 1 | 0 | 0 | 0 | 0 | 66.7 | 33.3 | 0 | 66.7 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Vinculin | Invasin ipaA | 3RF3_A_C | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2C-m6 TCR | H2-L plus QL9-Ld peptide | 2E7L_EQ_AD | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2C TCR | H2-L plus QL9-Ld peptide | 2OI9_AQ_BC | 1 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HLA-A2 plus Tel1- peptide | A6 TCR | 3H9S_ABC_DE | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CAR D1 domain | AD37 knob protein | 2J12_A_B | 1 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Leech metallocarboxypeptidase inhibitor | Carboxypeptidase A | 2ABZ_B_E | 1 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Complement C3d | Ehp | 2NOJ_A_B | 1 | 0 | 1 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ALL COMPLEXES: | 7086 | 1846 | 443 | 9.4 | 18.4 | 37.3 | 13.1 | 21.8 | 39.6 | 4067 | 194 | 280 | 2651 | 1438 | 561 | 481 | 363 | 355 | 324 | 265 | 184 | 132 | 129 | 64 | 44 | 25 | 22 | 48 |